Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-23-001473

Chief Operating Officer gave up 2,450 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Devroe Eric · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-11-14 Shares withheld for taxes : show line 1 in the form −2,450 $5.08 $12,446 60,433 D
Loading xslF345X05/form4.xml…